Stock listing
Imagion Biosystems Ltd.
Selected listing: IBXXF · OTC · USD · US
Imagion Biosystems Ltd. (OTC:IBXXF), Health Technology. Latest release Sep 30, 2026: IBX Secures Central Ethics Approval - Key Phase 2 Milestone.
- Ticker
- OTC:IBXXF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Imagion Biosystems Ltd.
Imagion Biosystems Ltd. (Ticker: IBX) is a public company based in Australia, focused on developing innovative medical imaging technologies.
Latest news from Imagion Biosystems Ltd.
IBX Secures Central Ethics Approval - Key Phase 2 Milestone
September 29, 2026
Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities
September 14, 2026
MagSense Nanoparticle Manufacturing Update
September 13, 2026
IBX Phase 2 Clinical Trial Update
August 25, 2026
Appendix 4C and Quarterly Activities Report - June 2026
July 30, 2026
Research Imagion Biosystems Ltd.
Imagion Biosystems Ltd. company profile
View the public company page for Imagion Biosystems Ltd. on 6ix.
Imagion Biosystems Ltd. news
Read company news and market updates connected to Imagion Biosystems Ltd..
Imagion Biosystems Ltd. investor events
Find investor webinars, events, and replay context for Imagion Biosystems Ltd..